ExPEC10V

VAC52416 · Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ExPEC10V, covering 2024-06-25 to 2024-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health [Phase 1, Phase 2]

See pricing